Currently, Ascendis Pharma A/S ADR [ASND] is trading at $155.86, up 3.35%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ASND shares have gain 2.13% over the last week, with a monthly amount glided 24.60%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ascendis Pharma A/S ADR [NASDAQ: ASND] stock has seen the most recent analyst activity on January 07, 2025, when UBS initiated its Buy rating and assigned the stock a price target of $196. Previously, Oppenheimer upgraded its rating to Outperform on September 05, 2024, and kept the price target unchanged to $180. On June 25, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $175 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $200 on May 31, 2024. Jefferies initiated its recommendation with a Buy and recommended $150 as its price target on December 20, 2023. In a note dated April 05, 2023, Oppenheimer downgraded an Perform rating on this stock.
This stock has fluctuated between a low of $111.09 and a high of $158.00 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $208.86 within the next 12 months. Ascendis Pharma A/S ADR [NASDAQ: ASND] shares were valued at $155.86 at the most recent close of the market. An investor can expect a potential return of 34.0% based on the average ASND price forecast.
Analyzing the ASND fundamentals
Trailing Twelve Months sales for Ascendis Pharma A/S ADR [NASDAQ:ASND] were 391.88M which represents 25.27% growth. Gross Profit Margin for this corporation currently stands at 0.88% with Operating Profit Margin at -0.77%, Pretax Profit Margin comes in at -1.03%, and Net Profit Margin reading is -1.04%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is 1.98 and Total Capital is -1.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-8.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 149.40 points at the first support level, and at 142.94 for the second support level. However, for the 1st resistance point, the stock is sitting at 159.15, and for the 2nd resistance point, it is at 162.44.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Ascendis Pharma A/S ADR [NASDAQ:ASND] is 1.17. Also, the Quick Ratio is 0.84, while the Cash Ratio stands at 0.62. Considering the valuation of this stock, the price to sales ratio is 23.80.
Transactions by insiders
Recent insider trading involved MIKKELSEN JAN MOLLER, Officer, that happened on Mar 05 ’25 when 7789.0 shares were purchased. Officer, Bodenhoff Mads completed a deal on Mar 05 ’25 to buy 2254.0 shares. Meanwhile, Officer Hartvig Camilla Harder bought 2222.0 shares on Mar 04 ’25.
